Anu Mohan - Blog

Participant Highlights from AAAAI 2021

Among the specific topics commanding healthcare professionals' (HCP) attention were the potential for Sanofi’s Dupixent in eosinophilic esophagitis, Amgen’s tezepelumab in uncontrolled asthma, and Lilly’s Olumiant in atopic dermatitis.

Covid-19

Q3 Earnings Calls Presented a Case for Cautious Optimism

Having weathered many challenges in Q2 2020, biopharmaceutical firms, by and large, presented a case for optimism during Q3 2020 earnings calls. However, alongside this optimistic outlook were a number of voices expressing

Covid-19

Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

Covid-19

Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

Covid-19

Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of

Conferences

ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics

Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to

Conferences

Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel

The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting. In